Cybn financials
WebCybin (CYBN) financials statements overview reports - Cybin's market cap is currently ―. The company's EPS TTM is -$0.22; its P/E ratio is -1.7, and it has a dividend yield of ―. WebWhat do you mean by lagging? Cybin market cap is worth 50% more than Numi and has a bigger gain since ipo. They’re also hard to compare as they’re two different companies with different strategies.
Cybn financials
Did you know?
WebCYBN chart Today 0.23% Week −0.23% 1 month −18.27% 6 months −24.01% Year to date −24.40% 1 year −42.09% 5 years −95.30% All time −97.78% Key stats Market capitalization 74.842M USD Dividends yield (FY) — Price to earnings Ratio (TTM) — Basic EPS (TTM) −0.2137 USD About Cybin Inc ISIN CA23256X1006 Sector Health Technology Industry WebCybin is a biotech company located in Ontario, Canada, which is part of the Healthcare sector, and is traded under the ticker CYBN on the NYSEMKT exchange. Cybin stock last closed at $0.37, down 1.84% from the previous day, and has decreased 53.94% in one year.
WebCYBN fundamentals Overview Statements Statistics Dividends Earnings Revenue CYBIN INC key financial stats and ratios If you want to check out CYBN market capitalization, P/E Ratio, EPS, ROI, and other financial ratios, this page is your go-to hub. Statistics Annual Quarterly More Q1 '21 Q2 '21 Q3 '21 Q4 '21 Q1 '22 Q2 '22 Q3 '22 0 WebApr 12, 2024 · Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“ Cybin ” or the “ Company ”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today announced the launch of EMBARK Open Access (“EMBARK OA”), a free online …
WebApr 6, 2024 · ( NYSEMKT: CYBN) Cybin currently has 191,138,717 outstanding shares. With Cybin stock trading at $0.39 per share, the total value of Cybin stock (market …
WebMar 30, 2024 · Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for...
WebMar 24, 2024 · Get the detailed income statement for Cybin Inc. (CYBN). Up to 10 years of financial statements. Quarterly or annual. View as % YoY growth or as % of revenue. barbapapaWebCybin Inc. (CYBN) NYSE American - NYSE American Delayed Price. Currency in USD. Follow. 2W 10W 9M. 0.3899 -0.0001 (-0.03%) At close: 04:00PM EDT. 0.3780 -0.01 ( … barbapapa 1hWebApr 6, 2024 · Detailed balance sheet for Cybin (CYBN), including cash, debt, assets, liabilities, and book value. ... Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC). Sections. Stocks; IPOs; ETFs; barbapapa 08WebFinancials Technicals Forecast CYBN fundamentals Overview Statements Statistics Dividends Earnings An in-depth look to CYBIN INC operating, investing, and financing activities CYBN free cash flow for Q3 22 is -10.77M CAD. For 2024, CYBN free cash flow was -45.31M CAD and operating cash flow was -45.21M CAD. Q1 '21 Q2 '21 Q3 '21 Q4 … barbapapa 1WebApr 12, 2024 · LOSERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed down 4.55% at $0.84 Compass Pathways (NASDAQ:CMPS) shares closed down 2.71% at $10.06 Cybin (AMEX:CYBN) shares closed down 2.10% at $0.38 ... barbapapa 1977WebCYBN Stock Price - Cybin, Inc. is an ethical biopharmaceutical company engaged in the development of therapeutics for patients to address a multitude of mental health issues. … barbapapa 1988WebNov 23, 2004 · Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and ... barbapapa 1974